Weight and visual field deficits in women with idiopathic intracranial hypertension

Journal of Women's Health

Volumn 19, Issue 10, 2010, Pages 1893-1898

  Baldwin, Maureen K ^a   Lobb, Brenna ^b   Tanne, Emanuel ^b   Egan, Robert ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Martin o'Neil Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CASE FINDING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; VISUAL FIELD DEFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MIDDLE AGED; RETROSPECTIVE STUDIES; VISION DISORDERS; VISUAL FIELDS; WEIGHT GAIN; YOUNG ADULT;

EID: 77958021956     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1804     Document Type: Article

References (18)

1. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45:875-877.
2. Radhakrishnan K, Sridharan R, Ashok PP, Mousa ME. Pseudotumour cerebri: Incidence and pattern in Northeastern Libya. Eur Neurol 1986;25:117-124. (Pubitemid 16168633)
3. Carta A, Bertuzzi F, Cologno D, Giorgi C, Montanari E, Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): Descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol 2004;14:48-54.
4. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001;21:12-14.
5. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155-180.
6. Wall M, George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol 1987;44:170-175.
7. Lehman CA. Idiopathic intracranial hypertension within the ICF model: A review of the literature. J Neurosci Nurs 2003;35:263-269.
8. Reid AC, Thomson JA. Absence of significant endocrine deficiencies in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1981;44:731-734.
9. Weisberg LA. Benign intracranial hypertension. Medicine (Baltimore) 1975;54:197-207.
10. Glueck CJ, Aregawi D, Goldenberg N, Golnik KC, Sieve L, Wang P. Idiopathic intracranial hypertension, polycysticovary syndrome, and thrombophilia. J Lab Clin Med 2005; 145:72-82. (Pubitemid 40298732)
11. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-1495.
12. Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm 1983;40:1016-1019.
13. Wacholder S. Binomial regression in GLIM: Estimating risk ratios and risk differences. Am J Epidemiol 1986;123:174-184.
14. Thompson ML, Myers JE, Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross-sectional data: What is to be done? Occup Environ Med 1998;55:272-277.
15. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: An empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3:21.
16. Lumley T, Kronmal R, Ma S. Relative risk regression in medical research: Models, contrasts, estimators, and algorithms. In: UW Biostatistics Working Paper Series, 2006.
17. Neville L, Egan RA. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005;40:775-777.
18. Whiteley W, Al-Shahi R, Warlow CP, Zeidler M, Lueck CJ. CSF opening pressure: Reference interval and the effect of body mass index. Neurology 2006;67:1690-1691.